BRANDING & PROMOTIONAL ACTIVITIES
NICOTINE REPLACEMENT THERAPY
Nicotine Replacement Therapy is a treatment to help people stop
smoking/chewing tobacco. It uses products that supply low doses of nicotine.
These products do not contain many of the toxins found in smoke/Tobacco. The
goal of therapy is to cut down on cravings for nicotine and ease the symptoms
of nicotine withdrawal.
Therapy Guide
20 AND MORE CIGARETTES – PATCH
20 AND MORE CIGARETTES – PATCH
20 AND MORE CIGARETTES – PATCH
LESS THAN 20 CIGARETTES – PATCH
LESS THAN 20 CIGARETTES – PATCH
LESS THAN 20 CIGARETTES – PATCH
Preparing to Quit Smoking
Just thinking about quitting may make you anxious. But
your chances will be better if you get ready first. Quitting
works best when you’re prepared. Before you
quit, START by taking these five important steps:
• S = Set a quit date
• T = Tell family, friends, and co-workers that you plan to quit
• A = Anticipate and plan for the challenges you’ll face while quitting
• R = Remove cigarettes and other tobacco products from your home, car, and work
• T = Talk to your doctor about getting help to quit
TRENDS
Cigarette smoking remained a major health
concern over the review period, with the
government further regulating cigarettes
sales in India. As such, these movements
benefited sales of NRT, the only category
present in smoking cessation aids in the
country.
According to International Countries &
Consumers data, smoking prevalence in
India is set to fall from 11.9% in 2009 to
11.5% in 2020, with an increasing number
of smokers trying to kick the habit.
COMPETITIVE LANDSCAPE
Johnson & Johnson retained its outright lead in the category in
2016, holding a 52% value share, down from 57% in the previous
year. Although the company continued to benefit from its first
mover advantage, much of its share decline was to the benefit of
“others” in the category.
SWOT ANALYSIS
SWOT ANALYSIS
STRENGTHS WEAKNESS
1. Very well accepted in the global markets, available
in more than 80 countries
2. Both GSK and J& have a strong presence in
pharmaceutical products with world class R&D and
product innovation, the brand benefits from that.
3. A wide range of products available: three flavors -
Original, Mint and Orange in different pack sizes to
address needs of different consumers
4. Nicorette was the first medicinal preparation to
facilitate smoking cessation and created a new
category referred to as Nicotine replacement
therapy.
1. Late entry in emerging economies
2. The brand has to work a lot in spreading
awareness especially in the rural markets where
reach of TV media is limited.
OPPORTUNITY THREATS
1. There are millions tobacco users & they
smoke and use tobacco in other forms like chewing
tobacco. This large size of cigarette users also results
in large number of health issues and in turn large
number of people who want to quit smoking.
2. The de marketing of cigarettes by government and
NGOs also increase the number of wannabe quitters.
1. Pharma products are subject to stringent legal
regulations; any mistake in adherence to quality etc.
can have strong implications.
2. The acceptance of product in Indian markets
would depend on cultural and social norms also. In
some regions, smoking is a part of the culture itself
and people might not readily accept the product.
COMPETITOR
• Nicoderm –
• Niconovum -
• Nicorette –
MARKET RESEARCH
• Analysis of key supply-side and
demand trends
• Detailed segmentation of
international and local products
• Historic volumes and values,
company and brand market shares
• Five year forecasts of market trends
and market growth
• Production, imports by origin,
exports by destination
• Robust and transparent market
research methodology, conducted
in-country
MARKET RESEARCH will answer
• What is the market size of NRT in India?
• What are the major brands in India?
• How have tobacco bans affected the sales of
NRT Smoking Cessation Aids?
Presented by: Nikhil WayngankarDate: 1st March 2017

2baconil - Nikhil - Rusan Pharma

  • 1.
  • 3.
    NICOTINE REPLACEMENT THERAPY NicotineReplacement Therapy is a treatment to help people stop smoking/chewing tobacco. It uses products that supply low doses of nicotine. These products do not contain many of the toxins found in smoke/Tobacco. The goal of therapy is to cut down on cravings for nicotine and ease the symptoms of nicotine withdrawal.
  • 4.
  • 5.
    20 AND MORECIGARETTES – PATCH
  • 6.
    20 AND MORECIGARETTES – PATCH
  • 7.
    20 AND MORECIGARETTES – PATCH
  • 8.
    LESS THAN 20CIGARETTES – PATCH
  • 9.
    LESS THAN 20CIGARETTES – PATCH
  • 10.
    LESS THAN 20CIGARETTES – PATCH
  • 11.
    Preparing to QuitSmoking Just thinking about quitting may make you anxious. But your chances will be better if you get ready first. Quitting works best when you’re prepared. Before you quit, START by taking these five important steps: • S = Set a quit date • T = Tell family, friends, and co-workers that you plan to quit • A = Anticipate and plan for the challenges you’ll face while quitting • R = Remove cigarettes and other tobacco products from your home, car, and work • T = Talk to your doctor about getting help to quit
  • 12.
    TRENDS Cigarette smoking remaineda major health concern over the review period, with the government further regulating cigarettes sales in India. As such, these movements benefited sales of NRT, the only category present in smoking cessation aids in the country. According to International Countries & Consumers data, smoking prevalence in India is set to fall from 11.9% in 2009 to 11.5% in 2020, with an increasing number of smokers trying to kick the habit.
  • 13.
    COMPETITIVE LANDSCAPE Johnson &Johnson retained its outright lead in the category in 2016, holding a 52% value share, down from 57% in the previous year. Although the company continued to benefit from its first mover advantage, much of its share decline was to the benefit of “others” in the category.
  • 14.
  • 15.
    SWOT ANALYSIS STRENGTHS WEAKNESS 1.Very well accepted in the global markets, available in more than 80 countries 2. Both GSK and J& have a strong presence in pharmaceutical products with world class R&D and product innovation, the brand benefits from that. 3. A wide range of products available: three flavors - Original, Mint and Orange in different pack sizes to address needs of different consumers 4. Nicorette was the first medicinal preparation to facilitate smoking cessation and created a new category referred to as Nicotine replacement therapy. 1. Late entry in emerging economies 2. The brand has to work a lot in spreading awareness especially in the rural markets where reach of TV media is limited. OPPORTUNITY THREATS 1. There are millions tobacco users & they smoke and use tobacco in other forms like chewing tobacco. This large size of cigarette users also results in large number of health issues and in turn large number of people who want to quit smoking. 2. The de marketing of cigarettes by government and NGOs also increase the number of wannabe quitters. 1. Pharma products are subject to stringent legal regulations; any mistake in adherence to quality etc. can have strong implications. 2. The acceptance of product in Indian markets would depend on cultural and social norms also. In some regions, smoking is a part of the culture itself and people might not readily accept the product.
  • 16.
    COMPETITOR • Nicoderm – •Niconovum - • Nicorette –
  • 17.
    MARKET RESEARCH • Analysisof key supply-side and demand trends • Detailed segmentation of international and local products • Historic volumes and values, company and brand market shares • Five year forecasts of market trends and market growth • Production, imports by origin, exports by destination • Robust and transparent market research methodology, conducted in-country
  • 18.
    MARKET RESEARCH willanswer • What is the market size of NRT in India? • What are the major brands in India? • How have tobacco bans affected the sales of NRT Smoking Cessation Aids?
  • 19.
    Presented by: NikhilWayngankarDate: 1st March 2017